India’s pharmaceuticals industry is thriving on the macro ills of the day. Private equity is well placed to benefit, but the opportunity set is no secret
As global private equity targets Indian pharmaceuticals with increasing regularity, so has a sneaking suspicion that the influx signals an inflection point. The theory is that the platform-style consolidations...
FountainVest Partners has set a target of $2.8 billion for its fourth China-focused fund, with a first close of more than $1 billion expected as soon as this week.
3D Diagnostic, a diagnostics spinout from Chinese tumor immunotherapy specialist 3D Medicines, has raised RMB1.5 billion ($224 million) in funding led by CPE, formerly known as CITIC Private Equity.
Ontario Teachers’ Pension Plan (OTPP) has led a $360 million equity investment in Singapore-based data center developer Princeton Digital Group (PDG).
Australian alternative protein producer V2Food has raised a A$77 million ($55 million) Series B round featuring Sequoia Capital China and Temasek Holdings.